Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Fleming

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Cancer|June 1, 1981
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimenE T Creagan, T R Fleming, J H Edmonson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapyC G Moertel, T R Fleming, J S Macdonald, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group studyT D Brown, P J Goodman, T R Fleming, et al.
Cancer|January 15, 1981
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group studyT D Brown, P J Goodman, T R Fleming, et al.
Hepatology (Baltimore, Md.)|November 1, 1989
Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizabilityP M Grambsch, E R Dickson, M Kaplan, et al.
Cancer|January 15, 1991
A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group studyL M Morrell, A Bach, S P Richman, et al.
Cancer Treatment Reports|December 1, 1987
Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group StudyW H Harvey, T R Fleming, D D Von Hoff, et al.
Cancer Treatment Reports|March 1, 1984
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group studyJ E Krook, T R Fleming, R T Eagan, et al.
The Journal of Urology|July 1, 1983
Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancerR P Myers, H Zincke, T R Fleming, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Cancer|June 1, 1981
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimenE T Creagan, T R Fleming, J H Edmonson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapyC G Moertel, T R Fleming, J S Macdonald, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group studyT D Brown, P J Goodman, T R Fleming, et al.
Cancer|January 15, 1981
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group studyT D Brown, P J Goodman, T R Fleming, et al.
Hepatology (Baltimore, Md.)|November 1, 1989
Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizabilityP M Grambsch, E R Dickson, M Kaplan, et al.
Cancer|January 15, 1991
A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group studyL M Morrell, A Bach, S P Richman, et al.
Cancer Treatment Reports|December 1, 1987
Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group StudyW H Harvey, T R Fleming, D D Von Hoff, et al.
Cancer Treatment Reports|March 1, 1984
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group studyJ E Krook, T R Fleming, R T Eagan, et al.
The Journal of Urology|July 1, 1983
Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancerR P Myers, H Zincke, T R Fleming, et al.
Pageof 12